文献速递皮肤肿瘤

高危皮肤鳞状细胞癌的基线与监测影像可检出亚临床病变

Detection of subclinical disease with baseline and surveillance imaging in high-risk cutaneous squamous cell carcinomas.
PubMed 文献 · J Am Acad Dermatol · 2019-11-02

该单中心回顾性研究分析了2017至2019年间87例原发性高危皮肤鳞状细胞癌的影像学管理影响,发现58%的肿瘤接受了监测影像,24%的影像检查改变了管理方案,21%的病例通过影像检出亚临床病变,其中56%的检出发生在治疗后2年内的监测影像中。

要点

  • 高危皮肤鳞状细胞癌的影像检查可改变约24%病例的管理。
  • 影像可检出约21%病例的亚临床病变。
  • 多数亚临床病变检出发生于治疗后2年内的监测影像。

核心结论

  • 影像检查可检出高危皮肤鳞状细胞癌的亚临床病变,但需前瞻性研究确定最佳筛查与监测策略。

主要发现

  • 87个原发高危皮肤鳞状细胞癌中48个(58%)接受了监测影像。
  • 248次影像检查中146次(59%)结果异常。
  • 42次(24%)影像检查改变了管理方案。
  • 21%的受检病例通过影像检出亚临床病变。
  • 56%的检出病变最初未被发现,而是在治疗后2年内的监测影像中发现。

临床怎么用

  • 对高危皮肤鳞状细胞癌患者可考虑基线与监测影像以发现亚临床病变。
  • 影像结果可能影响管理决策,需结合临床判断。

局限性

  • 单中心回顾性设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are limited studies on imaging for management of high-risk cutaneous squamous cell carcinoma (HRCSSC). OBJECTIVE: To evaluate the impact of baseline (ie, at diagnosis) and surveillance (ie, subsequent time points after diagnosis) imaging on management of HRCSCCs. METHODS: All primary CSSCs treated at Brigham and Women's Hospital Mohs Surgery Clinic and Dana-Farber Cancer Institute High-Risk Skin Cancer Clinic from January 1, 2017 through June 1, 2019, were reviewed to identify tumors that underwent baseline or surveillance imaging. Tumors that underwent imaging were reviewed to determine the impact of imaging on management and ability of imaging to identify subclinical disease. RESULTS: Eighty-three patients underwent imaging for 87 primary HRCSCCs, of which 48 (58%) underwent surveillance imaging. A total of 146 (59%) abnormal results were obtained from 248 imaging studies. Management was altered by 42 (24%) studies. Imaging detected subclinical disease in 21% of cases studied. A majority (56%) of detections were not seen initially but rather during surveillance imaging in the 2 years after treatment. LIMITATIONS: Single institution retrospective design. CONCLUSIONS: Imaging identifies subclinical disease in HRCSCC. Prospective studies are needed to determine best practices for screening and surveillance in HRCSCC.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Maher JM, Schmults CD, Murad F, et al. Detection of subclinical disease with baseline and surveillance imaging in high-risk cutaneous squamous cell carcinomas. J Am Acad Dermatol. 2019. PMID: 31689446. doi:10.1016/j.jaad.2019.10.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。